(Q71604075)

English

Steady-state plasma concentrations and effects of taxol for a 250 mg/m2 dose in combination with granulocyte-colony stimulating factor in patients with ovarian cancer

scientific article published on 01 January 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505722%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Steady-state plasma concentrations and effects of taxol for a 250 mg/m2 dose in combination with granulocyte-colony stimulating factor in patients with ovarian cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505722%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

C A Jamis-Dow

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505722%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

R W Klecker

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505722%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

G Sarosy

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505722%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

E Reed

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505722%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

J M Collins

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505722%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

publication date

1 January 1993

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505722%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505722%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

33

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505722%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505722%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

48-52

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505722%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

https://scigraph.springernature.com/pub.10.1007/bf00686022

0 references

Taxol stabilizes microtubules in mouse fibroblast cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7505722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypersensitivity reactions from taxol

1 reference

https://pubmed.ncbi.nlm.nih.gov/7505722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Taxol assembles tubulin in the absence of exogenous guanosine 5'-triphosphate or microtubule-associated proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/7505722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct photoaffinity labeling of tubulin with taxol

1 reference

https://pubmed.ncbi.nlm.nih.gov/7505722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical and pharmacokinetic study of taxol.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7505722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/7505722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac disturbances during the administration of taxol

1 reference

https://pubmed.ncbi.nlm.nih.gov/7505722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7505722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Taxol metabolism. Isolation and identification of three major metabolites of taxol in rat bile

1 reference

https://pubmed.ncbi.nlm.nih.gov/7505722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7505722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of taxol in patients with malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7505722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antineoplastic Agents from Plants

1 reference

https://pubmed.ncbi.nlm.nih.gov/7505722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7505722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic response to taxol of six human tumors xenografted into nude mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7505722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Taxol produces a predominantly sensory neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7505722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia

1 reference

https://pubmed.ncbi.nlm.nih.gov/7505722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of taxol administered as a short i.v. infusion daily for 5 days.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7505722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I trial of taxol given by a 6-hour intravenous infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/7505722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

1 reference

https://pubmed.ncbi.nlm.nih.gov/7505722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00686022

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505722%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505722%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71604075&oldid=1754708871"